These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21756930)

  • 1. Glutamate mediated signaling in the pathophysiology of autism spectrum disorders.
    Choudhury PR; Lahiri S; Rajamma U
    Pharmacol Biochem Behav; 2012 Feb; 100(4):841-9. PubMed ID: 21756930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurochemical basis for the treatment of autism spectrum disorders and Fragile X Syndrome.
    Hampson DR; Adusei DC; Pacey LK
    Biochem Pharmacol; 2011 May; 81(9):1078-86. PubMed ID: 21333634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell adhesion molecules and their involvement in autism spectrum disorder.
    Ye H; Liu J; Wu JY
    Neurosignals; 2010; 18(2):62-71. PubMed ID: 21212702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate-mediated signaling and autism spectrum disorders: emerging treatment targets.
    Yang P; Chang CL
    Curr Pharm Des; 2014; 20(32):5186-93. PubMed ID: 24410563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of glutamate and its receptors in autism spectrum disorder.
    Nisar S; Bhat AA; Masoodi T; Hashem S; Akhtar S; Ali TA; Amjad S; Chawla S; Bagga P; Frenneaux MP; Reddy R; Fakhro K; Haris M
    Mol Psychiatry; 2022 May; 27(5):2380-2392. PubMed ID: 35296811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neurobiology of lipid metabolism in autism spectrum disorders.
    Tamiji J; Crawford DA
    Neurosignals; 2010; 18(2):98-112. PubMed ID: 21346377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1.
    Palmieri L; Papaleo V; Porcelli V; Scarcia P; Gaita L; Sacco R; Hager J; Rousseau F; Curatolo P; Manzi B; Militerni R; Bravaccio C; Trillo S; Schneider C; Melmed R; Elia M; Lenti C; Saccani M; Pascucci T; Puglisi-Allegra S; Reichelt KL; Persico AM
    Mol Psychiatry; 2010 Jan; 15(1):38-52. PubMed ID: 18607376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autism spectrum disorder and genes for synaptic proteins].
    Shishido E
    Brain Nerve; 2012 Jan; 64(1):65-70. PubMed ID: 22223503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of glutamate transporters in the pathophysiology of major mental illnesses].
    Tanaka K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Aug; 29(4):161-4. PubMed ID: 19764483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathways underlying the gut-to-brain connection in autism spectrum disorders as future targets for disease management.
    de Theije CG; Wu J; da Silva SL; Kamphuis PJ; Garssen J; Korte SM; Kraneveld AD
    Eur J Pharmacol; 2011 Sep; 668 Suppl 1():S70-80. PubMed ID: 21810417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synapse dysfunction in autism: a molecular medicine approach to drug discovery in neurodevelopmental disorders.
    Spooren W; Lindemann L; Ghosh A; Santarelli L
    Trends Pharmacol Sci; 2012 Dec; 33(12):669-84. PubMed ID: 23084458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting.
    Betancur C
    Brain Res; 2011 Mar; 1380():42-77. PubMed ID: 21129364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autism, genetics and synaptic function alterations].
    Perche O; Laumonnier F; Baala L; Ardourel MY; Menuet A; Robin V; Mortaud S; Montécot-Dubourg C; Richard O; Pichon J; Briault S
    Pathol Biol (Paris); 2010 Oct; 58(5):381-6. PubMed ID: 20181440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autism spectrum disorders.
    Tonge B; Brereton A
    Aust Fam Physician; 2011 Sep; 40(9):672-7. PubMed ID: 21894273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decoding the contribution of dopaminergic genes and pathways to autism spectrum disorder (ASD).
    Nguyen M; Roth A; Kyzar EJ; Poudel MK; Wong K; Stewart AM; Kalueff AV
    Neurochem Int; 2014 Jan; 66():15-26. PubMed ID: 24412511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional cerebral blood flow in children with autism spectrum disorders: a quantitative ⁹⁹mTc-ECD brain SPECT study with statistical parametric mapping evaluation.
    Yang WH; Jing J; Xiu LJ; Cheng MH; Wang X; Bao P; Wang QX
    Chin Med J (Engl); 2011 May; 124(9):1362-6. PubMed ID: 21740749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders.
    Herbert MR
    Curr Opin Neurol; 2010 Apr; 23(2):103-10. PubMed ID: 20087183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A possible central mechanism in autism spectrum disorders, part 1.
    Blaylock RL
    Altern Ther Health Med; 2008; 14(6):46-53. PubMed ID: 19043938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated plasma levels of glutamate in children with autism spectrum disorders.
    Cai J; Ding L; Zhang JS; Xue J; Wang LZ
    Neuroreport; 2016 Mar; 27(4):272-6. PubMed ID: 26825346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.